'Mindfulness' exercises help curb stress and fatigue associated with arthritis
December 20, 2011 in Arthritis & Rheumatism"Mindfulness" exercises, which focus on experiencing the present moment, no matter how difficult, can help curb the stress and fatigue associated with painful rheumatoid joint disease, indicates a small study published online in the Annals of Rheumatic Diseases.
The authors base their findings on 73 patients between the ages of 20 and 70, all of whom had had painful joint disease, caused by rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis for at least a year.
Half of them were randomly allocated to scheduled "mindfulness" exercises, which took place in 10 group sessions over a period of 15 weeks, plus a booster session around six months after the course had completed.
The sessions, which were facilitated by healthcare professionals trained in mindfulness techniques, addressed particular topics, such as recognising individual limitations, and strong emotions, such as anger, joy, and sorrow.
The exercises, which were part of the Vitality Training Programme of VTP, encouraged participants to become aware of, and deliberately concentrate on their feelings, thoughts and bodily experiences, including pain, without judging or trying to avoid them.
Participants were also given creative exercises, such as guided imagery, music and drawing, and shared their experiences with other members of the group.
The rest of the volunteers randomly allocated to the comparison group were given standard care plus a CD containing similar exercises for use at home, as and when they wanted.
Stress levels, coping abilities, and symptom control, including pain and fatigue, were assessed, using validated scores, immediately after all 10 sessions had finished, and again 12 months later.
In total, 67 participants completed all the assessments. These showed no differences in pain levels, disease activity or the ability to talk about feelings.
But there were significant differences in levels of stress and fatigue.
The number of participants with a high stress score of above 23 in the GHQ-20 questionnaire fell from 13 at the start of the study to two, just 12 months after the sessions had finished. Comparable figures in the comparison group were 10 and eight, respectively.
There was, however, a tangible fall in measured levels of fatigue in the intervention group: no such change was evident in the comparison group.
There have been previous attempts to use psychological and educational tactics to help people with arthritis cope better with the distressing aspects of the disease, but they have tended to be short term, say the authors.
The lasting improvements found with the VTP course "indicate that the participants may have incorporated some mindfulness strategies into their daily lives and that these strategies have strengthened their ability to respond to their stressful experience in a more flexible way," they say.
The authors emphasise that while the treatment of rheumatoid arthritis has improved greatly, it is less effective in those with more established disease, and that ultimately the disease can only be partly controlled, forcing many patients to make very demanding lifestyle changes.
"There is therefore a need for complementary interventions that enhance individuals' health-promoting resources and help them adjust to their disease," they conclude.
More information: To be published at http://ard.bmj.com
Provided by
British Medical Journal
-
Mindfulness meditation may ease fatigue, depression in multiple sclerosis
Sep 27, 2010 |
not rated yet |
0
-
Exercise program improves symptoms in arthritis patients
Jan 04, 2008 |
not rated yet |
0
-
Regular tipple may curb risk of rheumatoid arthritis
Jun 05, 2008 |
not rated yet |
0
-
Low impact aerobic exercise reduces fatigue in auto-immune conditions says multi-study review
Nov 29, 2006 |
not rated yet |
0
-
Mindfulness meditation increases well-being in adolescent boys
Sep 01, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Force in a magnetic coupling
9 hours ago
-
Sign of scalar product in electric potential integral?
16 hours ago
-
Heat engines: how can we yield work?
17 hours ago
-
Work done by us on the spring
May 25, 2012
-
Surface current density
May 25, 2012
-
Work done on body moving in a circle
May 25, 2012
- More from Physics Forums - Classical Physics
More news stories
Gender, high DAS28-P index predictive of pain in early RA
(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness and visual ...
Arthritis & Rheumatism
May 18, 2012 |
not rated yet |
0
New biomarker test predicts arthritis at much earlier stage
More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which ...
Arthritis & Rheumatism
May 15, 2012 |
4 / 5 (1) |
0
|
Systemic sclerosis complications more severe in African Americans than Caucasians
African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), ...
Arthritis & Rheumatism
May 10, 2012 |
not rated yet |
0
FDA panel urges approval for Pfizer arthritis drug
An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.
Arthritis & Rheumatism
May 09, 2012 |
not rated yet |
0
Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis
Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory lines of evidence. Now, researchers ...
Arthritis & Rheumatism
May 08, 2012 |
not rated yet |
0
|
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.